Real-time enrollment status for this recurrent glioblastoma, idh-wildtype clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:43 AM UTC
| NCT Number | NCT06410248 |
| Recruiting Status | Recruiting |
| Condition | Recurrent Glioblastoma, IDH-Wildtype |
| Phase | Clinical Trial |
| Target Enrollment | 30 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Northwestern University |
| Last Updated on CT.gov | May 1, 2026 (May 1, 2026) |
As of July 13, 2026: Clinical trial NCT06410248 is currently recruiting participants. This clinical trial study for recurrent glioblastoma, idh-wildtype is actively seeking new participants at 1 location across the United States. The study is sponsored by Northwestern University. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06410248 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06410248 was last updated May 1, 2026 (May 1, 2026). HelloStudys verifies this status automatically.